China’s CanSino, Sinopharm unit, seek approval for Covid vaccines
3-D holographic microscopy powered by deep-learning deciphers cancer immunotherapy
24 February 2021India to vaccinate over-60s from March 1
24 February 2021China’s CanSino, Sinopharm unit, seek approval for Covid vaccines
China’s CanSino Biologics and a unit of Sinopharm said Wednesday they have applied for public use of their COVID-19 vaccines, and announced efficacy rates.
